Surgical Robotics Industry in the US

Part
01
of one
Part
01

Surgical Robotics Industry in the US

The surgical robotics industry in the US appears to be led by Intuitive Surgical and Stryker, with many other companies offering a variety of surgical systems. There have been several new systems launched over the past two years, with their launches and FDA approvals covered by a variety of websites. Among these, massdevice.com and therobotreport.com seem to be major sources of this news.

Top Market Players

Intuitive Surgical

  • Intuitive Surgical held 38.1% of the market share in 2019.
  • In 2018, they had 3,196 systems installed in the US.
  • Intuitive Surgical has two surgical systems. Their da Vinci surgical system provides minimally invasive surgeries; Ion is a robotic-assisted platform for minimally invasive peripheral lung biopsies.

Stryker

  • Stryker held 10.63% of the MedSurg market share in 2019.
  • The company has 523 Mako robots installed in the US.
  • Stryker's Mako is for robotic-arm assisted surgery, in hip and knee replacements.

Smith & Nephew

  • Smith & Nephew has an 11% share in the hip and knee implants market, which their surgical system falls under.
  • The company that created NAVIO was purchased for $275 million in 2016.
  • The NAVIO Surgical System is a handheld instrument used for partial and total knee arthroplasty.

Accuray

  • Industry-related revenue is expected to hit $100.8 million in 2019. This gives it an absolute market share of 100.8 million / 3.4 billion = 2.96%.

Medtronic

  • There were 114 Mazor X systems installed in the US in 2017.
  • Mazor Robotics, the company that manufactures Mazor X systems, is estimated to have an annual revenue of $67.6 million. This gives an estimate of an absolute market share of 67.6 million / 3.4 billion = 1.99%.
  • The company has several surgical systems. The Mazor X is a robotic guidance system for spinal surgery; Stealth Autoguide is a cranial robotic guidance platform. Medtronic also plans to launch Hugo RAS, a robot-assisted surgery platform.

Stereotaxis

  • Stereotaxis had an annual revenue of $27.8 million in 2018. This gives an estimate of an absolute market share of 27.8 million / 3.4 billion = 0.818%.
  • Niobe and Genesis are both robotic magnetic navigation systems, allowing a physician to steer and control a magnet.
  • Vdrive is a robotic navigation system, providing remote control of diagnostic devices.

TransEnterix

  • The company had an annual revenue of $24.1 million in 2018. This gives an estimate of an absolute market share of 24.1 million / 3.4 billion = 0.709%.
  • TransEnterix installed 21 systems from 2016 to 2018.
  • The company designed the Senhance Surgical System. This is a digital laparoscopic platform and a multi-port robotic system. They also designed the SPIDER Surgical System and the SurgiBot system, a robotic laparoscopic surgical platform.

Auris Health, Inc

  • The company was purchased in 2019 by Johnson & Johnson for $3.4 billion.
  • The Monarch Platform, their surgical system, is designed for peripheral bronchoscopy.


Newly Launched Systems

Medtronic Cranial Robot

Ion

CorPath System

Monarch Platform

da Vinci SP

TSolution One

Hugo RAS

  • Hugo RAS was unveiled by Medtronic in 2019, who plan to launch it in early 2020.
  • Hugo RAS is a new robot-assisted surgery platform. The system boasts modularity, universal use, the potential for upgrades, an open console and is based on existing surgical tool expertise.
  • This news was reported by sites such as massdevice.com, orthofeed.com, and startribune.com.

Research Strategy

In order to determine the top players in the market, we looked into pre-compiled lists of major players in the US and global markets, such as Top 10 Robotic Surgery Companies in the United States and Robotic Assisted Surgery System Market 2019. Looking into these companies revealed that some overlapped, for example, Medtronic owns Mazor Robotics. We then investigated these companies to determine the volume of installed systems and market share. For some, market share was unavailable so we formed an estimate based on the revenue of the company and the total revenue of the industry, $3.4 billion. This allowed us to confirm that the companies were the top players.

To find newly launched systems, we searched for news articles reporting launches of surgical systems or FDA approvals of these robotic surgical systems. This allowed us to determine the largest releases in the past two years, which we then investigated further to determine the details. Many of these FDA approvals were reported by very many websites, so a selection was given.
Sources
Sources